Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Asia: Healthcare's Biggest M&A Opportunity And Challenge
Forbes
Thursday, September 19, 2013 - 11:05am
tags:
M&A, Asia
Aerie Pharma jumps into IPO game with $58M pitch to investors
Fierce Biotech
Thursday, September 19, 2013 - 8:21am
tags:
Aerie Pharma, IPOs
Google's biotech plan: Partner with legendary CEO, tackle aging, think outside the cancer box
Fierce Biotech
Thursday, September 19, 2013 - 8:19am
tags:
Google, biotech, aging, Larry Page, Art Levinson, Calico
Gilead revenue growth likely to accelerate, says Bernstein
Yahoo/Fly on the Wall
Thursday, September 19, 2013 - 8:17am
tags:
Gilead
Illumina's verifi prenatal test shows positive results in aneuploidies detection
Yahoo/Fly on the Wall
Thursday, September 19, 2013 - 8:16am
tags:
Illumina, aneuploidies, verifi
How Far Can $69 Million Take Protalix?
Motley Fool
Thursday, September 19, 2013 - 3:32am
tags:
Protalix BioTherapeutics
Teva Payout Counters Copaxone Exclusivity Loss
Bloomberg/Businessweek
Thursday, September 19, 2013 - 3:16am
tags:
Teva, Copaxone, MS, multiple sclerosis
Athersys: A Potential Stroke Therapy Monopoly On Hand
Seeking Alpha
Thursday, September 19, 2013 - 3:14am
tags:
stroke, Athersys, Cytomedix, MultiStem
[video]Biotech IPOs With Big Partners
TheStreet.com
Thursday, September 19, 2013 - 3:13am
tags:
biotech, IPOs, Celgene, Amgen, Bind Therapeutics, Acceleron, Fate Therapeutics
5 Things You Need to Know From BioMarin's R&D Day
Motley Fool
Thursday, September 19, 2013 - 3:09am
tags:
R&D, Biomarin, Vimizim, BMN-701, BMN-111, BMN-673
Is Roche a Small Biotech's Best Friend?
Motley Fool
Thursday, September 19, 2013 - 3:01am
tags:
Roche, Inovio, Curis
Approval? Check. Partner? Not So Much.
Motley Fool
Thursday, September 19, 2013 - 3:00am
tags:
Dendreon, Provenge, Europe
Bacterin: New CEO Positions Company For Growth
Seeking Alpha
Thursday, September 19, 2013 - 2:59am
tags:
Bacterin, Pharma CEOs, Dan Goldberger
3 Companies Racing to Transform Hepatitis-C Treatment
Motley Fool
Thursday, September 19, 2013 - 2:58am
tags:
hepatitis C, Gilead, sofosbuvir, AbbVie, Bristol-Myers Squibb, daclatasvir, asunaprevir, BMS-791325
Pharma suffers in China as widening scandal spooks docs, reps
Fierce Pharma
Wednesday, September 18, 2013 - 12:54pm
tags:
China, physicians, drug reps
Analyst Sees Big Risks Lurking in Possible Biotech Buyout
Yahoo/24-7 Wall St
Wednesday, September 18, 2013 - 12:44pm
tags:
ViroPharma, Sanofi, M&A, Shire
[video]What's Holding This Big Pharma Back?
Motley Fool
Wednesday, September 18, 2013 - 12:42pm
tags:
AstraZeneca
Medtronic wins a round in patent spat with Edwards Lifesciences
Mass Device
Wednesday, September 18, 2013 - 11:47am
tags:
Medtronic, patents, Edwards Lifesciences, devices, heart valves
Update on Arena/Eisai's Belviq
Yahoo/Zacks
Wednesday, September 18, 2013 - 11:39am
tags:
Arena Pharmaceuticals, Belviq, obesity, Eisai
Repros reported additional topline results from study for Androxal
Yahoo/Fly on the Wall
Wednesday, September 18, 2013 - 10:37am
tags:
Androxal, Repros Therapeutics, testosterone

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.